Otros idiomas BioMarin Pharmaceutical Inc.

Acciones

BMRN

US09061G1013

Farmacéuticos

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 09/02/2026			Variación 5 días	Varia. 1 de enero.
57,81 ^USD	-0,55 %		-0,24 %	-2,73 %

26/01	Actualización del sector: Las acciones de salud registran resultados mixtos en la preapertura del lunes	MT
26/01	BioMarin Pharmaceutical planea una emisión de bonos por 850 millones de dólares y asegura un préstamo sindicado de 2.000 millones	MT

Otros idiomas

29/01	BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility
26/01	Sector Update: Health Care Stocks Mixed Premarket Monday
26/01	Biomarin Pharmaceutical Inc. Announces $850 Million of Senior Unsecured Notes Due 2034
26/01	BioMarin Pharmaceutical Plans $850 Million Notes Offering, Lines Up $2 Billion Syndicated Loan
26/01	BioMarin announces proposed private offering of senior notes and syndication of new senior secured term loan facility
26/01	BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility
21/01	When America Starts to Feel Like a Risky Asset
20/01	Greenland, Tariffs, and the Quiet Revolt of the Bond Market
20/01	Analyst recommendations: Intel, Philip Morris, Duolingo, Netflix, SanDisk…
13/01	BioMarin Pharmaceuticals Aims for Sustained Growth in 2026, Wedbush Says
13/01	BioMarin Pharmaceutical Reports Preliminary 2025 Revenue, Details Asset Write-Down
12/01	Biomarin Pharmaceutical Inc estimates $3.2 billion in total revenues for FY - SEC filing
12/01	BioMarin Pharmaceutical Names Arpit Dave Chief Digital and Information Officer
12/01	BioMarin Appoints Arpit Davé Chief Digital and Information Officer
12/01	BioMarin Pharmaceutical Inc. Appoints Arpit Davé as Executive Vice President and Chief Digital and Information Officer
08/01	BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
08/01	Veeva Systems, BioMarin Pharmaceutical Enter Long-Term Partnership
08/01	Veeva and Biomarin form long-term strategic partnership
08/01	Veeva and BioMarin Form Long-Term Strategic Partnership
22/12	BioMarin Pharmaceutical Inc. Announces its Decision to Discontinue Development of BMN349
19/12	Health Care Up Amid Deal Activity -- Health Care Roundup
19/12	Wall Street optimistisch het weekend in
19/12	MÄRKTE USA/Zinssenkungshoffnung stützen Börse - Oracle fest
19/12	Sector Update: Health Care Stocks Rise Late Afternoon
19/12	Sector Update: Health Care Stocks Higher Friday Afternoon

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Artículos de MarketScreener Estrategias MarketScreener Ideas de trading

Otros idiomas BioMarin Pharmaceutical Inc.

Acciones

BMRN

US09061G1013

Farmacéuticos

Otros idiomas

Filtros